{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:08:33Z","timestamp":1780708113011,"version":"3.54.1"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cyto.2025.157063","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:57:30Z","timestamp":1761559050000},"page":"157063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Inflammation and inflammatory cytokines in cardiac cachexia: an incendiary issue"],"prefix":"10.1016","volume":"196","author":[{"given":"Amisha","family":"Mahur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhoomika M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2025.157063_bb0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: a systematic overview","volume":"121","author":"von Haehling","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cyto.2025.157063_bb0010","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2147\/CIA.S273967","article-title":"Cardiac cachexia: a well-known but challenging complication of heart failure","volume":"15","author":"Krysztofiak","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.cyto.2025.157063_bb0015","doi-asserted-by":"crossref","first-page":"L24","DOI":"10.1093\/eurheartj\/suz241","article-title":"Cardiac cachexia","volume":"Suppl. 21","author":"Lena","year":"2019","journal-title":"Eur. Hear. Journal"},{"key":"10.1016\/j.cyto.2025.157063_bb0020","article-title":"The complex pathophysiology of cardiac cachexia: a review of current pathophysiology and implications for clinical practice","author":"Thanapholsart","year":"2022","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cyto.2025.157063_bb0025","series-title":"C Ardiac cachexia in Early Literature: a Review of Research Prior to Medline","author":"Doehner","year":"2002"},{"key":"10.1016\/j.cyto.2025.157063_bb0030","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1002\/ehf2.13052","article-title":"Clinical problems of patients with cachexia due to chronic illness: a congress report","volume":"7","author":"Hadzibegovic","year":"2020","journal-title":"ESC Hear. Fail."},{"key":"10.1016\/j.cyto.2025.157063_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cyto.2025.157063_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells11061039","article-title":"Interconnection between cardiac Cachexia and heart failure\u2014protective role of cardiac obesity","volume":"11","author":"Soto","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2025.157063_bb0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jcsm.12118","article-title":"Cardiac cachexia: hic et nunc","author":"Loncar","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.cyto.2025.157063_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.hfc.2019.08.006","article-title":"Cardiac Cachexia revisited: the role of wasting in heart failure","volume":"16","author":"Valentova","year":"2020","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.cyto.2025.157063_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.cyto.2025.157063_bb0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13539-014-0152-z","article-title":"Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones","volume":"5","author":"Josiak","year":"2014","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.cyto.2025.157063_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13539-011-0020-z","article-title":"Cachexia in heart disease: highlights from the ESC 2010","volume":"2","author":"Kung","year":"2011","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.cyto.2025.157063_bb0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/hrt.2002.007005","article-title":"Inflammatory mediators in chronic heart failure: An overview","volume":"90","author":"Anker","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.cyto.2025.157063_bb0075","article-title":"Inflammatory cytokines, immune cells, and organ interactions in heart failure","volume":"12","author":"Li","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","article-title":"Muscle wasting and cachexia in heart failure: mechanisms and therapies","volume":"14","author":"Von Haehling","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/RRCC.S41513","article-title":"Cardiac cachexia and muscle wasting: definition, physiopathology, and clinical consequences","author":"Okoshi","year":"2014","journal-title":"Res. Reports Clin. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0090","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCULATIONAHA.115.020894","article-title":"Gastrointestinal and liver issues in heart failure","volume":"133","author":"Sundaram","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2025.157063_bb0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11897-013-0153-9","article-title":"Mechanisms for cachexia in heart failure","volume":"10","author":"Pureza","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.cyto.2025.157063_bb0100","series-title":"CARDIAC CACHEXIA SYNDROME","author":"Andr\u00e9","year":"2017"},{"key":"10.1016\/j.cyto.2025.157063_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcsm.12043","article-title":"Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training","volume":"6","author":"Bowen","year":"2015","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.cyto.2025.157063_bb0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10741-015-9501-z","article-title":"Resuscitation of a dead cardiomyocyte","volume":"20","author":"Kunkel","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cyto.2025.157063_bb0115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10741-019-09784-3","article-title":"Pharmacological management of cardiac cachexia: a review of potential therapy options","volume":"24","author":"Rolfe","year":"2019","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cyto.2025.157063_bb0120","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/hc4201.097836","article-title":"Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic\/catabolic factors","volume":"104","author":"Nagaya","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2025.157063_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1054\/jcaf.2003.23","article-title":"Growth hormone resistance in chronic heart failure and its therapeutic implications","volume":"9","author":"Cicoira","year":"2003","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.cyto.2025.157063_bb0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12020-012-9725-9","article-title":"Testosterone and heart failure","volume":"42","author":"Volterrani","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.cyto.2025.157063_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1570161053586868","article-title":"The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology","volume":"3","author":"Sharma","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.cyto.2025.157063_bb0140","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/eje.0.1450727","article-title":"Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia","volume":"145","author":"Doehner","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cyto.2025.157063_bb0145","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1378\/chest.115.3.836","article-title":"Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation","volume":"115","author":"Anker","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.cyto.2025.157063_bb0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/RRCC.S41513","article-title":"Cardiac cachexia and muscle wasting: definition, physiopathology, and clinical consequences","author":"Okoshi","year":"2014","journal-title":"Res. Reports Clin. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0155","series-title":"Angiotensin II as Candidate of Cardiac cachexia","author":"Delafontaine","year":"2025"},{"key":"10.1016\/j.cyto.2025.157063_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2016.05.071","article-title":"Animal models of cardiac cachexia","volume":"219","author":"Molinari","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MAJ.0000000000000511","article-title":"Mechanisms of cachexia in chronic disease states","volume":"350","author":"Yoshida","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cyto.2025.157063_bb0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cyto.2025.157063_bb0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s13539-012-0098-y","article-title":"Sources for skeletal muscle repair: from satellite cells to reprogramming","volume":"4","author":"Sirabella","year":"2013","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.cyto.2025.157063_bb0180","first-page":"1","article-title":"Sarcopenia\u00a0: current insights into molecular mechanisms","author":"Tu","year":"2025","journal-title":"Diagnostics, and Emerging Interventional Approaches"},{"key":"10.1016\/j.cyto.2025.157063_bb0185","first-page":"1","article-title":"Emerging targets and treatments for sarcopenia: a narrative review","volume":"16","author":"Cacciatore","year":"2024","journal-title":"Nutr"},{"key":"10.1016\/j.cyto.2025.157063_bb0190","article-title":"Regulation of satellite cells functions during skeletal muscle regeneration: a critical step in physiological and pathological conditions","volume":"25","author":"Careccia","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2025.157063_bb0195","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/med.2610120605","article-title":"The role of cytokines in muscle wasting: its relation with cancer cachexia","volume":"12","author":"Argils","year":"1992","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cyto.2025.157063_bb0200","series-title":"the potential for TNF antagonism a a","author":"Sharma","year":"2002"},{"key":"10.1016\/j.cyto.2025.157063_bb0205","series-title":"T he Syndrome of Cardiac cachexia","author":"Anker","year":"2002"},{"key":"10.1016\/j.cyto.2025.157063_bb0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-5273(99)00186-2","article-title":"The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1","volume":"72","author":"Sharma","year":"2000","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0215","series-title":"Imbalance of Catabolic and Anabolic Pathways in Chronic Heart Failure Implications for the Treatment of Cardiac cachexia","author":"Anker","year":"2002"},{"key":"10.1016\/j.cyto.2025.157063_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells13030252","article-title":"Molecular mechanisms of Cachexia: a review","volume":"13","author":"Neshan","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2025.157063_bb0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.cyto.2025.157063_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9103267","article-title":"Complexity of TNF-\u03b1 signaling in heart disease","volume":"9","author":"Rolski","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cyto.2025.157063_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-5699(92)90116-O","article-title":"Two TNF receptors","volume":"13","author":"Tartaglia","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cyto.2025.157063_bb0240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.14219\/jada.archive.2002.0127","article-title":"A matter of life and death","volume":"133","author":"Jeffcoat","year":"2002","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.cyto.2025.157063_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01675","article-title":"Forward and reverse signaling mediated by transmembrane tumor necrosis factor-alpha and TNF receptor 2: potential roles in an immunosuppressive tumor microenvironment","volume":"8","author":"Qu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.157063_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-2187-8-12","article-title":"Membrane TNF-alpha-activated programmed necrosis is mediated by ceramide-induced reactive oxygen species","volume":"8","author":"Ardestani","year":"2013","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.cyto.2025.157063_bb0255","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cellsig.2012.02.006","article-title":"Signal transduction by tumor necrosis factor receptors","volume":"24","author":"Cabal-Hierro","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cyto.2025.157063_bb0260","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","article-title":"Selected cytokine pathways in rheumatoid arthritis","volume":"39","author":"Noack","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.cyto.2025.157063_bb0265","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","article-title":"The role and regulation of MAFbx\/atrogin-1 and MuRFl in skeletal muscle atrophy","volume":"461","author":"Foletta","year":"2011","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0270","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cell.2010.08.004","article-title":"Reversing cachexia","volume":"142","author":"Tisdale","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2025.157063_bb0275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/rr67","article-title":"Tumor necrosis factor-\u03b1 and muscle wasting: a cellular perspective","volume":"2","author":"Reid","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.cyto.2025.157063_bb0280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00926829","article-title":"Acute treatment with tumour necrosis factor-\u03b1 induces changes in protein metabolism in rat skeletal muscle","volume":"125","author":"Garc\u00eda-Mart\u00ednez","year":"1993","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cyto.2025.157063_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052274","article-title":"Exercise training prevents TNF-\u03b1 induced loss of force in the diaphragm of mice","volume":"8","author":"Mangner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2025.157063_bb0290","first-page":"625","article-title":"Failure\u00a0: a community study","volume":"118","author":"Roger","year":"2009","journal-title":"Heal. San Fr."},{"key":"10.1016\/j.cyto.2025.157063_bb0295","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12265-016-9710-4","article-title":"Serial echocardiographic characteristics, novel biomarkers and Cachexia development in patients with stable chronic heart failure","volume":"9","author":"Gaggin","year":"2016","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.cyto.2025.157063_bb0300","first-page":"168","volume":"38","author":"Carson","year":"2011","journal-title":"NIH Public Access"},{"key":"10.1016\/j.cyto.2025.157063_bb0305","series-title":"Interleukin-6 and Cardiovascular Diseases","first-page":"183","author":"Anda","year":"2003"},{"key":"10.1016\/j.cyto.2025.157063_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.cyto.2025.157063_bb0315","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cyto.2025.157063_bb0320","series-title":"gp130-mediated pathway and heart failure","first-page":"427","volume":"4","year":"2008"},{"key":"10.1016\/j.cyto.2025.157063_bb0325","first-page":"287","article-title":"Role of interleukins in heart failure with reduced ejection fraction, Anatol","volume":"22","author":"Segiet","year":"2019","journal-title":"J. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00500","article-title":"The JAK\/STAT pathway in skeletal muscle pathophysiology","volume":"10","author":"Moresi","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0335","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cyto.2025.157063_bb0340","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.biocel.2013.04.025","article-title":"Muscle wasting in heart failure: An overview","volume":"45","author":"von Haehling","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cyto.2025.157063_bb0345","series-title":"IL-6 Deficiency Attenuates Skeletal Muscle Atrophy by Inhibiting Mitochondrial ROS Production through the Upregulation of PGC-1 \u03b1 in Septic Mice, 2022","author":"Yang","year":"2022"},{"key":"10.1016\/j.cyto.2025.157063_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells13090783","article-title":"Withaferin a as a potential therapeutic target for the treatment of angiotensin II-induced cardiac Cachexia","volume":"13","author":"Vemuri","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2025.157063_bb0355","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.0000156469.96135.0D","article-title":"Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats","volume":"111","author":"Janssen","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2025.157063_bb0360","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cyto.2025.157063_bb0365","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2005.06.006","article-title":"Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure","volume":"109","author":"Toth","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0370","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00005-009-0024-y","article-title":"Nikolaos Frangogiannis, the role of Interleukin-1 in the pathogenesis of heart disease","volume":"57","author":"Bujak","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.cyto.2025.157063_bb0375","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2025.157063_bb0380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11897-014-0231-7","article-title":"Targeting Interleukin-1 in heart failure and inflammatory heart disease","volume":"12","author":"Van Tassell","year":"2015","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.cyto.2025.157063_bb0385","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF00568631","article-title":"Alkaloids of Delphinium corumbosum","volume":"9","author":"Narzullaev","year":"1973","journal-title":"Chem. Nat. Compd."},{"key":"10.1016\/j.cyto.2025.157063_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and skeletal muscle wasting during Cachexia","volume":"11","author":"Webster","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0395","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.emboj.7601587","article-title":"Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38\u03b1 in abrogating myoblast proliferation","volume":"26","author":"Perdiguero","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.cyto.2025.157063_bb0400","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbrc.2010.04.067","article-title":"Role of AP-1 and RE-1 binding sites in matrix metalloproteinase-2 transcriptional regulation in skeletal muscle atrophy","volume":"396","author":"Liu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2025.157063_bb0405","first-page":"1","article-title":"Interleukin-1 beta a potential link between stress.pdf","author":"Speaker","year":"2012","journal-title":"Biomed Cent. Physiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228592","article-title":"Cachexia, a systemic disease beyond muscle atrophy","volume":"21","author":"Wyart","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2025.157063_bb0415","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.1995.269.5.E852","article-title":"Interleukin-1\u03b2-induced anorexia and pyrexia in rat: relationship to hypothalamic neuropeptide Y","volume":"269","author":"McCarthy","year":"1995","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2025.157063_bb0420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Scheede-Bergdahl","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.cyto.2025.157063_bb0425","first-page":"706","article-title":"Interleukin-1 stimulates catabolism in C2C12 myotubes","volume":"297","author":"Li","year":"2009","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.cyto.2025.157063_bb0430","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20111020","article-title":"Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis","volume":"208","author":"Braun","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157063_bb0435","article-title":"Cachectin\/TNF or IL-1\u03b1 induced cachexia with redistribution of body proteins","volume":"256","author":"Fong","year":"1989","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.cyto.2025.157063_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033438","article-title":"Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure","volume":"7","author":"van Tassell","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2025.157063_bb0445","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","article-title":"Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"83","author":"Aukrust","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0450","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-015-0497-y","article-title":"The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia","volume":"32","author":"Bilir","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cyto.2025.157063_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.559220","article-title":"Signaling via the Interleukin-10 receptor attenuates cardiac hypertrophy in mice during pressure overload, but not isoproterenol infusion","volume":"11","author":"Stafford","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cyto.2025.157063_bb0460","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/wound.2019.1032","article-title":"The role of the anti-inflammatory cytokine Interleukin-10 in tissue fibrosis","volume":"9","author":"Steen","year":"2020","journal-title":"Adv. Wound Care"},{"key":"10.1016\/j.cyto.2025.157063_bb0465","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"10.1016\/j.cyto.2025.157063_bb0470","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.immuni.2014.03.011","article-title":"Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function","volume":"40","author":"Shouval","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.157063_bb0475","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.112.112185","article-title":"Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-\u03baB","volume":"126","author":"Verma","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2025.157063_bb0480","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9149(02)02494-3","article-title":"Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure","volume":"90","author":"Bolger","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0485","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1152\/japplphysiol.01079.2007","article-title":"Effects of IL-10 and age on IL-6, IL-1\u03b2, and TNF-\u03b1 responses in mouse skeletal and cardiac muscle to an acute inflammatory insult","volume":"104","author":"Meador","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0490","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.103.2.220","article-title":"Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure","volume":"103","author":"Gullestad","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2025.157063_bb0495","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2019.00140","article-title":"The role of the TGF-\u03b2 superfamily in myocardial infarction","volume":"6","author":"Hanna","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cyto.2025.157063_bb0505","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","article-title":"Balancing the activation state of the endothelium via two distinct TGF-\u03b2 type I receptors","volume":"21","author":"Goumans","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.cyto.2025.157063_bb0510","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2025.157063_bb0515","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Par\u00e9","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2025.157063_bb0520","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.22232","article-title":"Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis","volume":"45","author":"Mendias","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cyto.2025.157063_bb0525","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2362.2006.01718.x","article-title":"Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure","author":"Shyu","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.cyto.2025.157063_bb0530","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1741826711402735","article-title":"Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure","volume":"19","author":"Lenk","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0535","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijcard.2007.07.058","article-title":"Hypothesis: Myostatin is a mediator of cardiac cachexia","volume":"124","author":"Hoenig","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.531785","article-title":"Interleukin-2 (IL-2) Interacts With IL-2 Receptor Beta (IL-2R \u03b2): Its Potential to Enhance the Proliferation of CD4 + T Lymphocytes in Flounder (Paralichthys olivaceus)","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2025.157063_bb0545","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low- \u00ad dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double- \u00ad blind, placebo- \u00ad controlled trial","author":"He","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2025.157063_bb0550","article-title":"The IL-2 \u2013 IL-2 receptor pathway\u00a0: key to understanding multiple sclerosis","volume":"4","author":"Peerlings","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.cyto.2025.157063_bb0555","volume":"5","author":"Matsuoka","year":"2014","journal-title":"NIH Public Access"},{"key":"10.1016\/j.cyto.2025.157063_bb0560","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of Interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.157063_bb0565","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1159\/000485818","article-title":"The IL-2\/anti-IL-2 complex attenuates cardiac Ischaemia-reperfusion injury through expansion of regulatory T cells","volume":"44","author":"Xiao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cyto.2025.157063_bb0570","doi-asserted-by":"crossref","first-page":"22913","DOI":"10.1074\/jbc.M116.729038","article-title":"Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of adherens junctions","volume":"291","author":"Wylezinski","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2025.157063_bb0575","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ehf2.15051","article-title":"IL-2R\u03b1 is a potential biomarker for heart failure diagnosis of patients with end-stage renal disease and haemodialysis","volume":"12","author":"Lv","year":"2025","journal-title":"ESC Hear. Fail."},{"key":"10.1016\/j.cyto.2025.157063_bb0580","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0585","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","article-title":"Effects of interleukin 17 on the cardiovascular system","volume":"16","author":"Robert","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2025.157063_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01558","article-title":"Biology of Interleukin-17 and its pathophysiological significance in Sepsis","volume":"11","author":"Ge","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.157063_bb0595","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.157063_bb0600","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41401-020-00580-6","article-title":"Interleukin-17 upregulation participates in the pathogenesis of heart failure in mice via NF-\u03baB-dependent suppression of SERCA2a and Cav1.2 expression","volume":"42","author":"Xue","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cyto.2025.157063_bb0605","first-page":"C814","article-title":"IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2\/STAT3 pathway","volume":"322","author":"Ying","year":"2022","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.cyto.2025.157063_bb0610","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1002\/ehf2.14968","article-title":"IL-17 is associated with disease severity and targetable inflammatory processes in heart failure","volume":"11","author":"Baumhove","year":"2024","journal-title":"ESC Hear. Fail."},{"key":"10.1016\/j.cyto.2025.157063_bb0615","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri3766","article-title":"The IL-20 subfamily of cytokines-from host defence to tissue homeostasis","volume":"14","author":"Rutz","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.157063_bb0620","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.cyto.2025.157063_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox10020275","article-title":"Anti-il-20 antibody protects against ischemia\/reperfusion-impaired myocardial function through modulation of oxidative injuries, inflammation and cardiac remodeling","volume":"10","author":"Tsai","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.cyto.2025.157063_bb0630","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/imm.13403","article-title":"IL-20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation","volume":"164","author":"Hsu","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2025.157063_bb0635","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cca.2020.06.048","article-title":"A single-center observational study on the expression of circulating interleukin-20 levels and predicting outcomes in human chronic heart failure: a 2-year follow-up cohort study: higher IL-20 levels suggest poorer outcomes in CHF patients","volume":"510","author":"Zhao","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cyto.2025.157063_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2024.1357343","article-title":"Interferons and interferon-related pathways in heart disease","volume":"11","author":"Tran","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cyto.2025.157063_bb0645","first-page":"3111","article-title":"IFN-\u03b3 induces apoptosis in human melanocytes by activating the JAK1\/STAT1 signaling pathway","volume":"22","author":"Su","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cyto.2025.157063_bb0650","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ajpath.2012.08.040","article-title":"Interferon-\u03b3 causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis","volume":"181","author":"Cosper","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2025.157063_bb0655","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000658-200211000-00016","article-title":"Interferon gamma modulates trauma-induced muscle wasting and immune dysfunction","volume":"236","author":"Madihally","year":"2002","journal-title":"Ann. Surg."},{"key":"10.1016\/j.cyto.2025.157063_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2024.1378327","article-title":"The relationship between inflammatory factors and heart failure: evidence based on bidirectional Mendelian randomization analysis","volume":"11","author":"Huang","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cyto.2025.157063_bb0665","first-page":"1","article-title":"Origin and list of DAMPS","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."},{"key":"10.1016\/j.cyto.2025.157063_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1582219","article-title":"Mitochondrial DNA depletion syndrome and its cardiac complication","volume":"12","author":"Bao","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cyto.2025.157063_bb0675","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1152\/advan.00058.2013","article-title":"Pattern recognition receptors in innate immunity, host defense, and immunopathology","volume":"37","author":"Suresh","year":"2013","journal-title":"Am. J. Physiol. - Adv. Physiol. Educ."},{"key":"10.1016\/j.cyto.2025.157063_bb0680","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-016-9593-0","article-title":"Skeletal muscle inflammation and atrophy in heart failure","volume":"22","author":"Lavine","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cyto.2025.157063_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.599511","article-title":"Damage-associated molecular patterns in myocardial infarction and heart transplantation: the road to translational success","volume":"11","author":"Silvis","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.157063_bb0690","first-page":"1","article-title":"Pharmacological inhibition of HMGB1 prevents muscle wasting","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cyto.2025.157063_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415522","article-title":"DAMPs released from Proinflammatory macrophages induce inflammation in cardiomyocytes via activation of TLR4 and TNFR","volume":"23","author":"Neu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2025.157063_bb0700","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1073\/pnas.1522288113","article-title":"Critical role of RAGE and HMGB1 in inflammatory heart disease","volume":"113","author":"Bangert","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2025.157063_bb0705","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-025-01165-8","article-title":"Immunometabolism in heart failure","author":"Andreadou","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0710","first-page":"C1837","article-title":"Inflammation in cancer cachexia: still the central tenet or just another player?","volume":"328","author":"Iaia","year":"2025","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.cyto.2025.157063_bb0715","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.01037","article-title":"The impact of immune cells on the skeletal muscle microenvironment during Cancer Cachexia","volume":"11","author":"VanderVeen","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0720","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1016\/j.clnu.2021.07.027","article-title":"Relevance of nutritional assessment and treatment to counteract cardiac cachexia and sarcopenia in chronic heart failure","volume":"40","author":"Fern\u00e1ndez-Pombo","year":"2021","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.cyto.2025.157063_bb0725","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5152\/ClinSciNutr.2019.62","article-title":"The effect of nutritional support on nutritional status and quality of life as well as on inflammatory markers and cardiac functions in patients with cardiac cachexia due to chronic heart failure","volume":"1","author":"\u00c7elik","year":"2019","journal-title":"Clin. Sci. Nutr."},{"key":"10.1016\/j.cyto.2025.157063_bb0730","first-page":"74","article-title":"Cardiac cachexia: perspectives for prevention and treatment","volume":"108","author":"Okoshi","year":"2017","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.cyto.2025.157063_bb0735","article-title":"Multimodal interventions for cachexia management","volume":"2023","author":"Reid","year":"2023","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T09:18:29Z","timestamp":1762593509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":147,"alternative-id":["S1043466625002108"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157063","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and inflammatory cytokines in cardiac cachexia: an incendiary issue","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"157063"}}